tiprankstipranks
Revvity (RVTY)
NYSE:RVTY
US Market
Want to see RVTY full AI Analyst Report?

Revvity (RVTY) Stock Forecast & Price Target

558 Followers
See the Price Targets and Ratings of:

RVTY Analyst Ratings

Moderate Buy
8Ratings
Moderate Buy
3 Buy
5 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Revvity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RVTY Stock 12 Month Forecast

Average Price Target

$104.75
▲(11.48% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Revvity in the last 3 months. The average price target is $104.75 with a high forecast of $125.00 and a low forecast of $90.00. The average price target represents a 11.48% change from the last price of $93.96.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"85":"$85","126":"$126","95.25":"$95.3","105.5":"$105.5","115.75":"$115.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$125.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":104.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$104.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[85,95.25,105.5,115.75,126],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,86.68,89.62769230769231,92.57538461538462,95.52307692307693,98.47076923076924,101.41846153846154,104.36615384615385,107.31384615384616,110.26153846153846,113.20923076923077,116.15692307692308,119.10461538461539,122.05230769230769,{"y":125,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,86.68,88.07000000000001,89.46000000000001,90.85000000000001,92.24000000000001,93.63000000000001,95.02000000000001,96.41,97.8,99.19,100.58,101.97,103.36,{"y":104.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,86.68,86.93538461538462,87.19076923076923,87.44615384615385,87.70153846153846,87.95692307692308,88.21230769230769,88.46769230769232,88.72307692307693,88.97846153846154,89.23384615384616,89.48923076923077,89.74461538461539,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":92.634,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.064,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.746,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.041,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.917,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.564,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.46,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.287,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.615,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.006,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.515,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.851,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.68,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$125.00Average Price Target$104.75Lowest Price Target$90.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on RVTY
Barclays
Barclays
$95$105
Hold
11.75%
Upside
Assigned
05/07/26
Barclays Keeps Their Hold Rating on Revvity (RVTY)
Stifel Nicolaus Analyst forecast on RVTY
Stifel Nicolaus
Stifel Nicolaus
$110$100
Hold
6.43%
Upside
Assigned
05/06/26
Revvity price target lowered to $100 from $110 at StifelRevvity price target lowered to $100 from $110 at Stifel
Goldman Sachs Analyst forecast on RVTY
Goldman Sachs
Goldman Sachs
$95$100
Hold
6.43%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Vir Biotechnology (NASDAQ: VIR) and Johnson & Johnson (NYSE: JNJ)
J.P. Morgan Analyst forecast on RVTY
J.P. Morgan
J.P. Morgan
$96$90
Hold
-4.21%
Downside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Option Care Health (NASDAQ: OPCH) and OnKure Therapeutics (NASDAQ: OKUR)
TD Cowen
$120
Buy
27.71%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY) and Relay Therapeutics (NASDAQ: RLAY)
Robert W. Baird
$129$125
Buy
33.04%
Upside
Reiterated
05/04/26
Revvity price target lowered to $125 from $129 at BairdRevvity price target lowered to $125 from $129 at Baird
Evercore ISI Analyst forecast on RVTY
Evercore ISI
Evercore ISI
$118$108
Buy
14.94%
Upside
Assigned
04/06/26
Revvity price target lowered to $108 from $118 at Evercore ISIRevvity price target lowered to $108 from $118 at Evercore ISI
Nephron
$90
Hold
-4.21%
Downside
Upgraded
03/26/26
Revvity upgraded to Hold from Sell at Nephron ResearchRevvity upgraded to Hold from Sell at Nephron Research
UBS Analyst forecast on RVTY
Unknown Analyst
UBS
Not Ranked
UBS
$115$120
Buy
27.71%
Upside
Reiterated
02/03/26
Revvity (RVTY) Receives a Buy from UBS
Wells Fargo
$107$110
Hold
17.07%
Upside
Reiterated
02/03/26
Wells Fargo Reaffirms Their Hold Rating on Revvity (RVTY)
Jefferies
$100$105
Hold
11.75%
Upside
Reiterated
02/02/26
Revvity price target raised to $105 from $100 at JefferiesRevvity price target raised to $105 from $100 at Jefferies
Bank of America Securities Analyst forecast on RVTY
Bank of America Securities
Bank of America Securities
$110
Hold
17.07%
Upside
Reiterated
02/02/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY) and Aktis Oncology, Inc. (NASDAQ: AKTS)
Citi Analyst forecast on RVTY
Unknown Analyst
Citi
Not Ranked
Citi
$135
Buy
Reiterated
01/05/26
Citi Sticks to Their Buy Rating for Revvity (RVTY)
Raymond James Analyst forecast on RVTY
Raymond James
Raymond James
$115
Buy
22.39%
Upside
Reiterated
10/28/25
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Revvity (NYSE: RVTY)
Guggenheim Analyst forecast on RVTY
Guggenheim
Guggenheim
Hold
Reiterated
10/27/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: HCA Healthcare (NYSE: HCA), Revvity (NYSE: RVTY) and ANI Pharmaceuticals (NASDAQ: ANIP)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on RVTY
Barclays
Barclays
$95$105
Hold
11.75%
Upside
Assigned
05/07/26
Barclays Keeps Their Hold Rating on Revvity (RVTY)
Stifel Nicolaus Analyst forecast on RVTY
Stifel Nicolaus
Stifel Nicolaus
$110$100
Hold
6.43%
Upside
Assigned
05/06/26
Revvity price target lowered to $100 from $110 at StifelRevvity price target lowered to $100 from $110 at Stifel
Goldman Sachs Analyst forecast on RVTY
Goldman Sachs
Goldman Sachs
$95$100
Hold
6.43%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Vir Biotechnology (NASDAQ: VIR) and Johnson & Johnson (NYSE: JNJ)
J.P. Morgan Analyst forecast on RVTY
J.P. Morgan
J.P. Morgan
$96$90
Hold
-4.21%
Downside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY), Option Care Health (NASDAQ: OPCH) and OnKure Therapeutics (NASDAQ: OKUR)
TD Cowen
$120
Buy
27.71%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY) and Relay Therapeutics (NASDAQ: RLAY)
Robert W. Baird
$129$125
Buy
33.04%
Upside
Reiterated
05/04/26
Revvity price target lowered to $125 from $129 at BairdRevvity price target lowered to $125 from $129 at Baird
Evercore ISI Analyst forecast on RVTY
Evercore ISI
Evercore ISI
$118$108
Buy
14.94%
Upside
Assigned
04/06/26
Revvity price target lowered to $108 from $118 at Evercore ISIRevvity price target lowered to $108 from $118 at Evercore ISI
Nephron
$90
Hold
-4.21%
Downside
Upgraded
03/26/26
Revvity upgraded to Hold from Sell at Nephron ResearchRevvity upgraded to Hold from Sell at Nephron Research
UBS Analyst forecast on RVTY
Unknown Analyst
UBS
Not Ranked
UBS
$115$120
Buy
27.71%
Upside
Reiterated
02/03/26
Revvity (RVTY) Receives a Buy from UBS
Wells Fargo
$107$110
Hold
17.07%
Upside
Reiterated
02/03/26
Wells Fargo Reaffirms Their Hold Rating on Revvity (RVTY)
Jefferies
$100$105
Hold
11.75%
Upside
Reiterated
02/02/26
Revvity price target raised to $105 from $100 at JefferiesRevvity price target raised to $105 from $100 at Jefferies
Bank of America Securities Analyst forecast on RVTY
Bank of America Securities
Bank of America Securities
$110
Hold
17.07%
Upside
Reiterated
02/02/26
Analysts Offer Insights on Healthcare Companies: Revvity (NYSE: RVTY) and Aktis Oncology, Inc. (NASDAQ: AKTS)
Citi Analyst forecast on RVTY
Unknown Analyst
Citi
Not Ranked
Citi
$135
Buy
Reiterated
01/05/26
Citi Sticks to Their Buy Rating for Revvity (RVTY)
Raymond James Analyst forecast on RVTY
Raymond James
Raymond James
$115
Buy
22.39%
Upside
Reiterated
10/28/25
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Revvity (NYSE: RVTY)
Guggenheim Analyst forecast on RVTY
Guggenheim
Guggenheim
Hold
Reiterated
10/27/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: HCA Healthcare (NYSE: HCA), Revvity (NYSE: RVTY) and ANI Pharmaceuticals (NASDAQ: ANIP)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Revvity

3 Months
xxx
Success Rate
24/37 ratings generated profit
65%
Average Return
+2.72%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.86% of your transactions generating a profit, with an average return of +2.72% per trade.
1 Year
Success Rate
22/37 ratings generated profit
59%
Average Return
+7.09%
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 59.46% of your transactions generating a profit, with an average return of +7.09% per trade.
2 Years
xxx
Success Rate
19/37 ratings generated profit
51%
Average Return
+8.96%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 51.35% of your transactions generating a profit, with an average return of +8.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RVTY Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
6
10
8
6
3
Hold
3
8
8
10
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
18
16
16
12
In the current month, RVTY has received 3 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. RVTY average Analyst price target in the past 3 months is 104.75.
Each month's total comprises the sum of three months' worth of ratings.

RVTY Financial Forecast

RVTY Earnings Forecast

Next quarter’s earnings estimate for RVTY is $1.24 with a range of $1.19 to $1.38. The previous quarter’s EPS was $1.06. RVTY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.
Next quarter’s earnings estimate for RVTY is $1.24 with a range of $1.19 to $1.38. The previous quarter’s EPS was $1.06. RVTY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.

RVTY Sales Forecast

Next quarter’s sales forecast for RVTY is $710.55M with a range of $701.30M to $736.50M. The previous quarter’s sales results were $711.12M. RVTY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.
Next quarter’s sales forecast for RVTY is $710.55M with a range of $701.30M to $736.50M. The previous quarter’s sales results were $711.12M. RVTY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year RVTY has Performed in-line its overall industry.

RVTY Stock Forecast FAQ

What is RVTY’s average 12-month price target, according to analysts?
Based on analyst ratings, Revvity’s 12-month average price target is 104.75.
    What is RVTY’s upside potential, based on the analysts’ average price target?
    Revvity has 11.48% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is RVTY a Buy, Sell or Hold?
          Revvity has a consensus rating of Moderate Buy which is based on 3 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Revvity’s price target?
            The average price target for Revvity is 104.75. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $125.00 ,the lowest forecast is $90.00. The average price target represents 11.48% Increase from the current price of $93.96.
              What do analysts say about Revvity?
              Revvity’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of RVTY?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.